Efficacy and tolerability of a combination of ofloxacin and tinidazole in the management of infectious diabetic foot ulcer

Journal of the Indian Medical Association

Volumn 101, Issue 5, 2003, Pages 329-332

  Joshi, Shashank ^a,b   Maroli, Suresh ^a,c   Moulick, N D ^a,c   Badhane, Supriya ^a,c   Joshi, Shilpa ^a,c   Sthalekar, Nitya ^a,c   Ambavane, Vrushali ^a,d   Patil, Rupali ^a,d   Abhyankar, Meghana ^a,d   Pawar, Dilip ^a,d  

^a LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

^b MGM Hospital   (India)

^c Asian Healthcare   (India)

^d Unichem Laboratories Ltd   (India)

Author keywords

Combination of ofloxacin and tinidazole; Diabetic foot ulcer; Efficacy and tolerability

Indexed keywords

OFLOXACIN; TINIDAZOLE;

ADULT; AMPUTATION; ANTIBIOTIC THERAPY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC FOOT; DRUG EFFICACY; DRUG TOLERABILITY; ESCHERICHIA COLI; FEMALE; FOOT ULCER; HUMAN; INFECTION; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TREATMENT FAILURE;

EID: 0141894376     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. King H, Aubert RE, Herman WH - Global burden of diabetes, 1995-2025 - prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414-31.
2. Kahn R - Consensus development conference on diabetic foot wound care. Diabetes Care 1999; 22: 1354-60.
3. Bal A - Diabetic foot: magnitude of the problem. J Indian Med Assoc 2002; 100: 155-7.
4. Reiber GE, Vileikyte L, Boyko EJ, Del Aguila M, Smith DG, Lavery LA, et al - Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999; 22: 157-62.
5. Sedroy Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M - Costs and duration of care for lower-extremity ulcers in patients with diabetes. Clin Ther 1998; 20: 169-81.
6. Albrant DH - APhA drug treatment protocols: management of foot ulcers in patients with diabetes. J Am Pharm Assoc 2000; 40: 467-74.
7. Kelvin WS - Antimicrobial therapy for diabetic foot infections. Postgrad Med 1999; 106: 22-8.
8. Dry LR, et al - The diabetic foot. Available at www.drdry.com/ foot.html accessed on October 18, 2002.
9. Lipsky BA, Pecoraro RE, Larson SA, et al - Outpatient management of uncomplicated lower extremity infections in diabetic patients. Arch Intern Med 1990; 150: 790-7.
10. Wagner FW - The dysvascular foot: a system of diagnosis and treatment. Foot Ankle Int 1981; 2: 64-122.
11. Lavery LA, Armstrong DG, Harkless LB - Classification of diabetic foot wounds. J Foot Ankle Surg 1996; 35: 528-31.
12. Nord CE, Kager L - Tinidazole-microbiology, pharmacology and efficacy in anaerobic infections. Infection 1983; 11: 54-60.
13. Lipsky BA, Baker PD, Landon GC, et al - Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens. Clin Infect Dis 1997; 24: 643-8.